InVivoMAb anti-mouse LAG-3

Bauché D, Joyce-Shaikh B, Jain R, et al. LAG3(+) Regulatory T Cells Restrain Interleukin-23-Producing CX3CR1(+) Gut-Resident Macrophages during Group 3 Innate Lymphoid Cell-Driven Colitis. Immunity. 2018,49(2):342-352.e5. doi: 10.1016/j.immuni.2018.07.007

Rouhani SJ, Eccles JD, Riccardi P, et al. Roles of lymphatic endothelial cells expressing peripheral tissue antigens in CD4 T-cell tolerance induction. Nat Commun. 2015,6:6771. doi: 10.1038/ncomms7771

Durham NM, Nirschl CJ, Jackson CM, et al. Lymphocyte Activation Gene 3 (LAG-3) modulates the ability of CD4 T-cells to be suppressed in vivo. PLoS One. 2014,9(11):e109080. doi: 10.1371/journal.pone.0109080

Erickson JJ, Rogers MC, Hastings AK, et al. Programmed death-1 impairs secondary effector lung CD8⁺ T cells during respiratory virus reinfection. J Immunol. 2014,193(10):5108-17. doi: 10.4049/jimmunol.1302208

Verhagen J, Wraith DC. Blockade of LFA-1 augments in vitro differentiation of antigen-induced Foxp3⁺ Treg cells. J Immunol Methods. 2014,414:58-64. doi: 10.1016/j.jim.2014.07.012

McGray AJ, Hallett R, Bernard D, et al. Immunotherapy-induced CD8+ T cells instigate immune suppression in the tumor. Mol Ther. 2014,22(1):206-18. doi: 10.1038/mt.2013.255

Goding SR, Wilson KA, Xie Y, et al. Restoring immune function of tumor-specific CD4+ T cells during recurrence of melanoma. J Immunol. 2013,190(9):4899-909. doi: 10.4049/jimmunol.1300271